,date,symbol,reportedCurrency,fillingDate,acceptedDate,period,revenue,costOfRevenue,grossProfit,grossProfitRatio,researchAndDevelopmentExpenses,generalAndAdministrativeExpenses,sellingAndMarketingExpenses,otherExpenses,operatingExpenses,costAndExpenses,interestExpense,depreciationAndAmortization,ebitda,ebitdaratio,operatingIncome,operatingIncomeRatio,totalOtherIncomeExpensesNet,incomeBeforeTax,incomeBeforeTaxRatio,incomeTaxExpense,netIncome,netIncomeRatio,eps,epsdiluted,weightedAverageShsOut,weightedAverageShsOutDil,link,finalLink,timestamp,est_time,est_date
0,2020-12-31,GUD.TO,CAD,2020-12-31,2020-12-31,FY,199519000.0,117829000.0,81690000.0,0.4094346904304853,11725000.0,38845000.0,35585000.0,16409000.0,0.0,229519000.0,3398000.0,25535000.0,-4465000.0,-0.02237882106466051,-30000000.0,-0.15036161969536735,51161000.0,32085000.0,0.1608117522641954,325000.0,42067000.0,0.21084207519083395,0.32,0.32,131783255,131985025,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,1620592877,16:41:17,20210509
1,2019-12-31,GUD.TO,CAD,2019-12-31,2019-12-31,FY,47461000.0,20543000.0,26918000.0,0.5671604053854744,3913000.0,24460000.0,7789000.0,2195000.0,39575000.0,60118000.0,1014000.0,3413000.0,-9244000.0,-0.19477044310065106,-12657000.0,-0.26668211794947433,12911000.0,22782000.0,0.48001517035039293,4749000.0,14517000.0,0.30587218979793934,0.1038720200547055,0.10358984444183435,139758522,140139220,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,1620592877,16:41:17,20210509
2,2018-12-31,GUD.TO,CAD,2018-12-31,2018-12-31,FY,12500000.0,2305000.0,10195000.0,0.8156,1991000.0,8467000.0,3588000.0,1979000.0,15978000.0,18283000.0,0.0,1932000.0,-3851000.0,-0.30808,-5783000.0,-0.46264,14313000.0,29464000.0,2.35712,5385000.0,24079000.0,1.92632,0.16858784508452482,0.16806140861550106,142827616,143275010,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,1620592877,16:41:17,20210509
3,2017-12-31,GUD.TO,CAD,2017-12-31,2017-12-31,FY,8634000.0,1585000.0,7049000.0,0.8164234422052351,2750000.0,8198000.0,3378000.0,1527000.0,15955000.0,17540000.0,0.0,1629000.0,-7277000.0,-0.8428306694463747,-8906000.0,-1.0315033588139912,3805000.0,21199000.0,2.455293027565439,3955000.0,17244000.0,1.9972202918693538,0.12078698139926716,0.12023707202899278,142763730,143416666,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,1620592877,16:41:17,20210509
4,2016-12-31,GUD.TO,CAD,2016-12-31,2016-12-31,FY,5940000.0,1550000.0,4390000.0,0.7390572390572391,1955000.0,9302000.0,532000.0,3894000.0,12226000.0,13776000.0,0.0,437000.0,-7399000.0,-1.2456228956228956,-7836000.0,-1.3191919191919192,6895000.0,23473000.0,3.9516835016835015,4913000.0,18560000.0,3.1245791245791246,0.1537400370284867,0.1530550959916866,120723270,121263522,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,1620592877,16:41:17,20210509
5,2015-12-31,GUD.TO,CAD,2015-12-31,2015-12-31,FY,1037000.0,428000.0,609000.0,0.5872709739633558,2707000.0,9086000.0,0.0,2860000.0,11917000.0,12345000.0,0.0,124000.0,-11184000.0,-10.784956605593058,-11308000.0,-10.90453230472517,29692000.0,37016000.0,35.69527483124397,2849000.0,34167000.0,32.94792671166827,0.36,0.35,96191285,96532104,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,1620592877,16:41:17,20210509
6,2014-12-31,GUD.TO,CAD,2014-12-31,2014-12-31,FY,365323.0,0.0,0.0,0.0,1028516.0,4283437.0,0.0,435388.0,5397142.0,5397142.0,23538.0,85189.0,-4946630.0,-13.540428607013519,-5031819.0,-13.773616772007237,132209124.0,131053632.0,358.73359191728963,5194760.0,125858872.0,344.5139561429201,2.198466883125424,2.196654144264468,57248473,57295716,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,1620592877,16:41:17,20210509
7,2013-12-31,GUD.TO,CAD,2013-12-31,2013-12-31,FY,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,139758522,139758522,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,https://www.sedar.com/ModifyCompanyDocumentSearchForm.do?lang=EN&company_search=Knight Therapeutics Inc&document_selection=0&industry_group=A&FromDate=13&FromMonth=05&FromYear=2000&ToDate=13&ToMonth=11&ToYear=2020&Variable=Issuer,1620592877,16:41:17,20210509
